Description
Release form
Tablets
Packing
200 pcs.
Pharmacological action of
Cerniton is a treatment for diseases of the prostate gland of plant origin.
Cernilton has an anti-inflammatory and decongestant effect, helps regulate metabolic processes.
One of the pharmacological properties of the drug is doses providing a full supply of vitamins to the body during parenteral nutrition
Cernilton has an anti-inflammatory and decongestant effect, helps regulate metabolic processes.
One of the pharmacological properties of the drug is doses providing a full supply of vitamins to the body during parenteral nutrition
Cernilton has an anti-inflammatory and decongestant effect, helps regulate metabolic processes.
One of the pharmacological properties of the drug is dosesdependent inhibition of COX and 5-lipoxygenase, which leads to inhibition of the synthesis of mediators of inflammation of the arachidonic acid cycle: prostaglandins and leukotrienes and, as a result, to reduce inflammation and swelling of the prostate tissue. The drug helps to eliminate pain.
Zernilton has a muscle relaxant effect, which leads to relaxation of the smooth muscle elements of the posterior wall of the urethra and improved urination.
The drug reduces the volume of the prostate by inhibiting 5-alpha reductase, selectively blocks alpha1-adrenergic receptors of the smooth muscle elements of the urethra, and has an antiandrogenic effect. Helps improve erectile function.
Indications
As part of complex therapy:
acute and chronic prostatitis, benign prostatic hyperplasia, benign prostatic hyperplasia in combination with prostatitis.
Contraindications
Hypersensitivity to the components of the drug.
Special instructions
The use of Cernilton in chronic bacterial prostatitis is possible only in combination with antibacterial agents, as directed and under the supervision of a physician.
Composition
1 tablet contains:
Active substances:
Graminex TM G60 (water-soluble fraction of microbiologically fermented plant pollen extract) – 60 mg
Graminex TM GFX (fat-soluble fraction of microbiological extracts) 3 microbiologically microcrystalline,
silicon dioxide colloidal,
magnesium stearate.
Dosage and administration
Zernilton is applied orally 30 minutes before a meal with a little water.
Acute prostatitis: 4 tablets 3 times a day. The duration of the course of treatment is determined by the attending physician and is usually 3 months.
Chronic prostatitis: 1 tablet 3-4 times a day. The duration of the course of treatment is determined individually by the attending physician and is usually from 3 to 6 months.
Benign prostatic hyperplasia: 2 tablets 3 times a day. The duration of the course of treatment is determined individually by the attending physician and is usually from 6 to 12 weeks, but can be increased to 6 months.
Side effects
Allergic reactions possible In rare cases, nausea may occur.
Storage conditions
Store in a dry, dark place, out of the reach of children, at a temperature not exceeding 25 ° C.
Expiration
5 years.
Deystvuyuschee substances
drug rastitelno origin
Prescription conditions from
pharmacies Without prescription
dosage form
ta notch
GraminÑks, United States
